“…Due to their widespread distribution, the overactivation of mast cells and eosinophils can impact multiple biological systems and organs, affecting cardiovascular, endothelial ( 191 , 192 ), epithelial, mucosal, microvascular ( 193 ), metabolic ( 194 ), muscular, gastrointestinal, and connective tissues ( 193 , 195 – 197 ) as well as peripheral, central and autonomic nervous system. This cascade of effects can contribute to the development of complex multi-system conditions, exemplified by ME/CFS, which manifests with a diverse range of comorbidities ( 198 ) such as connective tissue disorders, small fiber neuropathy, migraine ( 199 – 201 ), POTS ( 202 , 203 ), immune system hypersensitivity ( 204 , 205 ), and dermatological manifestations (e.g., dermatitis, tingling or numbness, sensitivity, and allodynia) ( 206 ), as well as neuroinflammation, GI disorders, leaky gut ( 207 ), and autoimmunity observed in many patients ( 82 , 143 , 208 – 213 ). The excessive response of mast cells and eosinophils, coupled with aberrant degranulation, not only has the potential to trigger or exacerbate congenital conditions but also contributes to the development of acquired forms ( 214 ).…”